Overview

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Status:
Completed
Trial end date:
2019-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain
Phase:
Phase 2
Details
Lead Sponsor:
Navipharm Corporation